USPTO serial 76239304
TAIJI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 3, 2004
- Examiner
- LEIPZIG, MARC J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with TAIJI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY
CHONGQING, CN
Other trademarks owned by TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY
TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Chongqing, CN
Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Chongqing, CN
Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Chongqing, CN
Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road, Suite 100Henderson, NV 89014United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for human use for use in the treatment of hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases, [ hepatitis, infectious diseases, arthritis, acne, neurological disease, of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of microorganisms for medical use in treating humans and for veterinary use in treating livestock, domesticated pets, and domesticated animals, for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; pharmaceutical preparations of organisms for use in the treatment of hypertension, headaches, dermatological diseases, cardiovascular diseases, lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, gastrointestinal diseases, allergies insomnia depression, anxiety, stress, urological diseases, diabetes, heart diseases, hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; ] drugs for medical use, namely, medications used to treat hypertension, headaches, [ dermatological diseases, ] cardiovascular diseases, [ lymphatic diseases, psychiatric diseases, skeletal diseases, muscular diseases, cancer, ] gastrointestinal diseases, [ allergies, insomnia, depression, anxiety, stress, urological diseases, diabetes, ] heart diseases [ , hepatitis, infectious diseases, arthritis, acne, neurological diseases of the nervous system, eye conditions, tendonitis, treatment of libido problems; foods for medically restricted diets ] | ACTIVE | May 20, 2000 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY
- Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
- Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
- Other trademarks owned by TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
- Other trademarks in Class 005
- Similar marks named TAIJI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jul 27, 2025 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jul 27, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 25, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Aug 26, 2024 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| Aug 26, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 1, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Aug 3, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 30, 2013 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 30, 2013 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 30, 2013 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Sep 30, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 27, 2013 | 89AF | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | — |
| Sep 27, 2013 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Sep 27, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2009 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Oct 6, 2009 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Sep 30, 2009 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Sep 30, 2009 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 1, 2009 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Jul 15, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 3, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 25, 2004 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 4, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2004 | FAXX | FAX RECEIVED | — |
| Mar 22, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 10, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 9, 2004 | PAPER RECEIVED | — | |
| Feb 5, 2004 | IUAF | USE AMENDMENT FILED | — |
| Aug 5, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 13, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 7, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 1, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2002 | REIN | REINSTATED | — |
| Jun 13, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2002 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Jun 7, 2002 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2001 | DOCK | ASSIGNED TO EXAMINER | — |